血管内静脉支架置入控制侵袭颅内静脉窦的脑膜瘤所致静脉高压的技术考量与长期结果
该回顾性研究纳入16例因颅内脑膜瘤致静脉窦受压而行支架置入的患者,中位临床随访8年。支架置入后所有患者视乳头水肿均消退,但9例出现症状性支架内再狭窄,5例尽管静脉窦管腔恢复仍持续头痛,5例因难治性支架内狭窄持续有症状。作者结论认为成功支架置入可获良好结果,尤其缓解视乳头水肿,但常需再次手术维持支架通畅,长期监测是必需的。
要点
- 支架置入后所有患者视乳头水肿消退,但9例出现症状性支架内再狭窄。
- 6例症状长期显著缓解,5例持续头痛,5例因难治性支架内狭窄持续有症状。
- 静脉狭窄常不局限于脑膜瘤部位,7例矢状窦脑膜瘤患者存在双侧横窦狭窄。
核心结论
- 对有症状的脑膜瘤阻塞静脉窦患者,成功支架置入受累节段可获良好结果,尤其缓解视乳头水肿。
- 但常需进一步手术维持支架通畅,其他部位静脉受压常同时存在,部分患者尽管原发病灶治疗成功仍持续有症状。
- 长期监测是必需的。
研究设计与样本
- 回顾性综述本机构全部16例因颅内脑膜瘤致静脉窦受压而行支架置入的患者。
- 就诊时所有患者均有头痛,9例有视乳头水肿;13例有1个脑膜瘤,3例有2个或以上。
- 3例既往接受过肿瘤切除和放疗,1例曾接受腰腹腔分流和放疗。
- 中位临床随访时间为8年(范围4个月至18年)。
主要发现
- 静脉窦狭窄常不局限于脑膜瘤部位,7例矢状窦脑膜瘤患者存在双侧横窦狭窄,类似特发性颅内高压所见。
- 11例仅跨越脑膜瘤所致狭窄置入支架;5例同时在其它静脉狭窄部位额外置入支架:1例跨越既往手术所致矢状窦缺损,4例跨越横窦非肿瘤性狭窄;1例还置入颈静脉支架。
- 9例在脑膜瘤部位出现症状性支架内再狭窄,其中8例接受进一步支架置入手术,恢复支架内管腔的成功程度不一;剩余1例晚期部分复发,正在重新评估。
- 支架置入后所有患者视乳头水肿均消退;6例所有症状长期显著缓解;5例尽管静脉窦管腔恢复仍持续头痛;5例因难治性支架内狭窄持续有症状。
- 所有诊断或治疗操作均无显著并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Meningiomas invading the intracranial venous sinuses may cause intracranial venous hypertension, papilledema, and visual compromise. Sinus resection and graft reconstructions, however, add significant complexity to tumor surgery, with the potential for increased morbidity. In this study, the authors explored whether venous sinus stenting might provide an alternative means of controlling venous hypertension that would be sustainable over the long term. METHODS: The authors performed a retrospective review of all 16 patients with intracranial meningiomas who underwent stenting at their institution for venous sinus compromise. At presentation, all had headache and 9 had papilledema. Thirteen patients had 1 meningioma and 3 had 2 or more. Three patients had had previous tumor resection and radiotherapy. One patient had been treated with a lumboperitoneal shunt and radiotherapy. The median length of clinical follow-up was 8 years (range 4 months-18 years). RESULTS: Venous sinus narrowing was often not confined to the site of meningioma, and bilateral transverse sinus narrowing, reminiscent of that seen in idiopathic intracranial hypertension, was present in 7 patients with sagittal sinus meningiomas. Eleven patients had stents placed solely across sinus narrowing caused by meningioma. Five patients had additional stents placed at other sites of venous narrowing at the same time: in one of these patients, a stent was placed across a defect in the sagittal sinus caused by previous surgery, and in the 4 other patients, stents were placed across nontumor narrowings of the transverse sinuses. In 1 patient, the jugular vein was also stented. Nine patients developed symptomatic in-stent restenosis at the meningioma site. Eight had further stenting procedures with variable success in restoring the in-stent lumen. The remaining patient, with a late partial relapse, is being reinvestigated. Papilledema resolved in all patients after stenting. Six patients experienced prolonged and very substantial relief of all symptoms. Five patients had persistent headache despite restoration of the sinus lumen. Five had persistent symptoms associated with resistant in-stent stenosis. There were no significant complications from any of the diagnostic or therapeutic procedures. CONCLUSIONS: In patients who are symptomatic with meningiomas obstructing the venous sinuses, successful stenting of the affected segment can give a good outcome, especially in terms of relieving papilledema. However, further procedures are often necessary to maintain stent patency, other areas of venous compromise frequently coexist, and some patients remain symptomatic despite apparently successful treatment of the index lesion. Long-term surveillance is a requirement.
引用
- Higgins JNP, Kirollos SRW, Helmy A, et al. Technical considerations and long-term results of endovascular venous stenting to control venous hypertension from meningiomas invading intracranial venous sinuses. J Neurosurg. 2023. PMID: 37724796. doi:10.3171/2023.6.JNS23607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。